Mumbai, Aug. 28 -- The initial public offer of Symbiotec Pharmalab received bids for 93,52,49,700 shares as against 1,31,24,929 shares on offer. The issue was subscribed 71.26 times.

The issue opened for bidding on 24 August 2026 and closed on 27 August 2026. The price band of the IPO was fixed between Rs 938 and 988 per share. An investor can bid for a minimum of 15 equity shares and multiples thereof.

The IPO comprised fresh issue of equity shares worth up to Rs 150 crore and an offer for sale aggregating up to Rs 1,607 crore by Satwani Holdings LLP, Rosewood Investments, and India Business Excellence Fund - III.

The objectives for the fresh issue includes Rs 112.5 crore for Prepayment/repayment of certain outstanding borrowings, and...